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ABSTRACT

PHLEBITIS RATES IN TRAUMA PATIENTS: PERIPHERAL INTRAVENOUS
CATHETERS STARTED IN OR OUTSIDE THE EMERGENCY DEPARTMENT

Ligia J. Zarate
College of Nursing
Master of Science

Peripheral catheter-related phlebitis is the inflammation of a superficial vein
that can lead to infection or thrombus formation if untreated. About 150 million
peripheral intravenous catheters (PIVC) are inserted in the United States each year with
phlebitis rates reported between 5% and 70%. Many PIVCs are started on trauma
patients, but the rate of phlebitis in trauma patients whether the PIVC is started outside
the emergency department (ED) or inside the ED is unknown. Therefore, the purpose of
this pilot study was to determine phlebitis rates in trauma patients when PIVC’s are
started inside or outside the emergency department. Variables investigated, which may
influence phlebitis rates were duration of time the catheter was in place, the anatomical
placement site of the PIVC, the catheter gauge, where the PIVC initially was placed
(inside or outside the ED), and the injury severity score (ISS). This was a prospective
descriptive design. Results indicated 432 catheters were placed inside or outside the ED
in trauma patients that met the inclusion criteria.

The overall phlebitis rate was 5.79 %. The rate of phlebitis when the PIVC was
started inside the ED was 2.92%. The rate of phlebitis when the PIVC was started outside
the ED was 6.94%. If the PIVC was started outside the ED by EMTs the rate was 6.09%.
When the PIVC was started outside the ED by paramedics the rate was 7.78%. There was
no significant difference in rates of phlebitis according to where the PIVC was started
when a Chi Square analysis was performed. No variables predicted phlebitis no matter
where the PIVC was started when regression analyses were conducted.
The rate of phlebitis in PIVCs started in the ED, or by EMTs or Paramedics outside
the ED in this study was similar to and low according to the literature. The Center for
Disease Control and Prevention (CDC) suggests removal of the PIVC within 48 hours if
placed under emergency situations. However in this study, phlebitis rates of trauma
patients meet the benchmark of best practice and perhaps removal of the PIVC within 48
hours should be reconsidered. Complete documentation of medical records was 87.4%.
However, best practice of recording information and patient response to treatment should
be higher.
Keywords: Phlebitis, Peripheral, Intravenous, Trauma, Injury Severity Score (ISS).
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INTRODUCTION
Intravenous (IV) therapy can have beneficial effects for patients by providing
hydration and stabilizing hemodynamics in various clinical conditions. Peripheral
intravenous catheters (PIVCs) are the most widely used devices for vascular access
(Center for Disease Control [CDC], 2002). In fact, there are about 150 million peripheral
intravenous catheters inserted in the United States annually (Gallant & Schultz, 2006).
Furthermore, infusion therapy is known to account for one third of all nosocomial
infections (Soifer, Borzak, Edlin, & Weinstein, 1998). However one negative effect of
prolonged catheter use is phlebitis.
A review of the literature on phlebitis reveals 5% to 70% of patients receiving
intravenous therapy develop phlebitis (Gallant & Schultz, 2006; Campbell, Trojanowski,
& Ackroyd-Stolarz, 2005), and phlebitis is the most common intravenous therapy
complication patients experience requiring removal of the cannula (Maki & Ringer, 1991;
Management of Peripheral Intravascular Devices, 1998). In fact, phlebitis rates increase
from 12% to 34% after the first day of IV therapy, followed by an increase of 35% to
65% after 48 hours post catheter placement (Gallant & Schultz). However, the difference
in incidence of phlebitis rates in trauma patients specifically is unknown.
Peripheral catheter-related phlebitis is defined as inflammation of a superficial vein
caused by irritation to the lining of the vessel (Gabriel, Bravery, Dougherty, Kayley,
Maister, & Scales, 2005). Phlebitis refers to the subjective clinical manifestation at an
access site with two of the following symptoms: redness, pain, swelling, palpable venous
cord, thrombosis or streak formation (Bregenzer, Conen, Sakmann, & Widmer,1998;
Maki & Ringer, 1991; Management of peripheral intravascular devices, 1998; Standards
for Infusion Therapy, 2005). Phlebitis can lead to infection or thrombus formation and
symptoms develop over hours to days and resolve in days to weeks (Fernandez, 2007).
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There are 3 types of phlebitis: mechanical, chemical, and infectious (Hamilton,
2006; Josephson, 2004). Mechanical phlebitis occurs when a peripheral intravenous
catheter (PIVC) is not secured properly, leading the catheter to change position within the
vein. Subsequent irritation causes vessel inflammation, which can result in a clot at the
distal end of the catheter, leading to platelet aggregation around the injured vessel.
Mechanical phlebitis can also occur if a cannula is too large for the vein and
consequently prevents free flow of blood around it (Josephson, 2004). Mechanical
phlebitis often leads to removal/replacement of the catheter (Shah, Ng, & Sinha, 2004).
Chemical phlebitis is caused by highly vesicant irritants, such as drugs, which lead
to thrombus formation, causing a sterile inflammation of the vein intima (Lanbeck,
Odenholt, & Riesbeck, 2004). In fact, drug irritation was indicated as the most significant
predictor of phlebitis (Catney, Hillis, Wakefield, Simpson, Domino, & Keller et al.,
2001). Other causes of chemical phlebitis are physicochemical properties of solutions,
with high or low osmolarities or pH (Bregenzer et al., 1998; Gabriel et al., 2005), as well
as antibiotics, blood products, and glucose containing fluids.
Infectious or bacterial phlebitis is caused when an infectious agent is introduced
onto the PIVC, this starts an inflammatory response. Infectious phlebitis can be caused by
contamination of the catheter tip anytime during IV insertion (Gabriel et al., 2005; Maki
& Ringer, 1991). Infectious phlebitis may also occur if a cannula is left in place longer
than recommended by the CDC.
Another possible variable related to the occurrence of phlebitis could be the
patient’s overall physical health. For example, inmunocompromised patients, and
critically ill patients susceptible to nosocomial infection or with host infections, are at
higher risk for developing phlebitis (Maki & Ringer, 1991).
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Within these types of phlebitis are several specific subcategories of causes.
Contamination at the insertion site during PIVC insertion and the length of time the PIVC
is left in place could be considered subcategories of the infection type. Mechanical
subcategories include the anatomical placement site of the PIVC, the gauge or size of the
catheter being used. The ISS could be considered a subcategory of the patient’s over all
physical health.
Infectious Types of Phlebitis: Contamination at the Insertion Site
Strict aseptic technique should be used by all healthcare professionals who initiate
IV therapy (Gabriel et al., 2005). Not using aseptic technique when starting a PIVC plays
an especially important role in the development of phlebitis, since cannulation itself
provides a portal of entry for microbes, consequently causing inflammation/infection
(Hindley, 2004). However, when PIVCs are inserted in an emergency situation, when
optimal attention to aseptic technique might not be feasible, there could be a higher
incidence of phlebitis. In fact, according to Lawrence and Lauro (1988) PIVCs started
outside of a hospital setting were 4.65 times more likely to develop phlebitis than those
started under aseptic conditions in the emergency department.
Infectious Types of Phlebitis: Duration of Catheter in Place
The amount of time the PIVC is left in place is a second possible cause of phlebitis.
The Center for Disease Control and Prevention (CDC) recommends rotating the PIVC
every 72-96 hours, to reduce both the risk of infection and patient discomfort associated
with phlebitis (2002). In fact, studies indicate the longer the PIVC is in place, the higher
the patients risks for developing phlebitis (Grune, Schrappe, Basten, Wenchel, & Stutzer,
2004; Schultz & Gallant, 2005).
Mechanical types of phlebitis: Anatomical Placement of the PIVC
The anatomical site of the PIVC placement is the third possible source of phlebitis.
Catheters can be placed in a peripheral arm vein, in the forearm, or hand. IV’s started in
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the lower extremities are more likely to develop thrombophlebitis, deep vein thrombosis
and on rare occasions, pulmonary embolus. Phlebitis can develop within all of these sites,
however the antecubital fossa, (the first choice PIVC placement in trauma patients due to
ease of access to larger veins), has been associated with an increased risk of phlebitis
(Hankins, Waldman, Lonsway, Hedrick & Perdu, 2001).
Mechanical types of phlebitis: PIVC Gauge and Size
The gauge of the IV catheter has also been identified as another cause of phlebitis.
The gauge size refers to the external diameter of the catheter lumen (Gabriel et al., 2005)
The Standards for IV therapy are to select the smallest gauge for the prescribed therapy
(Standards for Infusion Therapy, 2005). For blood infusions or rapid infusion, larger
cannulae should be used (14-16 gauges). For crystalloids, smaller size gauges (18-20) are
recommended. For intermittent administration of drugs, an even smaller gauge (20-24
gauge) is recommended (Waitt, Waitt, & Pirmohamed, 2004). Despite wider gauge and
shorter catheter lengths permit faster infusions, (Gabriel et al., 2005) the larger the
catheter, the higher the risk of phlebitis (CDC, 2002). Critical patients require large bore
IVs for immediate resuscitation efforts and are therefore at higher risk for developing
phlebitis.
Patient’s Overall Physical Health: Injury Severity Score (ISS)
A final possible cause of phlebitis may be a patient’s ISS. The ISS was developed
in 1974 by Baker and O’Neill (1976) and yields a specific probability of survival for
patients with multiple injuries. It is the most widely used scale of injury for trauma
patients (Offner, 2002). The ISS calculates the Abbreviated Injury Score (AIS) values of
injury in six body areas: head and neck (score=1), face (=2), chest (=3), abdomen and
pelvic contents (=4), extremities and pelvis (=5), and general and cutaneous (=6). The
ISS is obtained by adding the three most severe areas and squaring the sum. Values range
from 0 to 75, the higher the score, the more critically ill the patient is.
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PURPOSE OF STUDY
Indeed, phlebitis continues to be a complication of PIVC use, and there are a
variety of possible situations linked to its occurrence. In addition, phlebitis rates in
patients whose PIVC was started outside the hospital are much higher than phlebitis rates
of patients whose PIVC was started inside the hospital. There also is no data available on
phlebitis rates of trauma patients. Therefore, the purpose of this pilot study was to
document the incidence of PIVC phlebitis rates in trauma patients when the PIVC was
started inside the emergency room by nurses and when the PIVC was started outside the
hospital setting by Emergency Medical Services [EMS] personnel, Paramedics, and
Intermediate/Basic Emergency Medical Technicians (EMTs). Variables investigated
which may influence phlebitis rates, are the length of time the PIVC was in place, the
anatomical insertion site of PIVC, the catheter gauge, whether the PIVC was placed
inside or outside the emergency department, the age and gender of the patient, and the
injury severity score (ISS).
Questions this project sought to answer were:
1.

What is the phlebitis rate in trauma patients?

2.

Is there a difference in phlebitis rates in trauma patients according to where
the PIVC was started?

3.

What variables predict phlebitis in trauma patients whose PIVC was started
in the emergency department?

4.

What variables predict phlebitis in trauma patients whose PIVC was started
outside the emergency department?

6

METHOD
Design
This pilot study used a prospective descriptive design.
Procedure
Institutional Review Board (IRB) approval was obtained from Brigham Young
University and Intermountain Healthcare Urban South Region prior to data collection.
Data was gathered at a 330-bed full-service tertiary and acute care referral center serving
Utah County and Central and Southern Utah. Upon receiving IRB approval, the medical
records of all trauma patients who were brought to the emergency department between
January 1 and December 31 of 2006 were reviewed. Data was gathered only on patients
who met the inclusion criteria. Prior to actual data collection, all patient identifying
information was removed.
Inclusion/Exclusion Criteria
The following three inclusion criteria were used: (a) all Trauma One and TraumaEvaluations (Eval) patients as listed per hospital protocol admitted to the emergency
department between January 1 and December 31 2006, (b) placement of PIVC either in
the emergency department or in the field prior to admission to the emergency department,
(c) admission to a hospital unit for at least 48 hours with intravenous catheters in place
for at least 24-48 hours. The criteria at this hospital for Trauma One is defined as
unstable vital signs including airway, a Glascow Coma Score (GCS) of less than eight, a
penetrating wound such as, a gunshot or stab, to the neck, thorax, or abdomen, and an
unstable patient who was transferred from another hospital who were receiving blood. A
Trauma One can also be determined by the Emergency Department physician or
Emergency Department Team Leader (Garry & Hill, 2005).
Trauma Eval patients include victims of an auto-pedestrian accident, experiencing
a fall greater than10-feet, a gunshot or stab wound to the head or areas other than the
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neck, thorax, or abdomen, a GCS greater than eight but less than thirteen, and a person
caught in a cave-in longer than thirty minutes. Other criteria for Trauma Evals include
disparity in vehicle size when involved in an accident, fatalities in the same accident,
persons ejected from a vehicle, aircraft accidents, patients suffering from two or more
fractures of proximal bones, a flail chest, a fractured pelvis, paralysis, a Burn Surface
Area (BSA) greater than 20% associated with major trauma or hemorrhage, a crush
injury to the torso or upper thighs, major amputation, or stable patients transferred from
another Emergency Department with any of the above injuries (Garry & Hill, 2005).
Three exclusion criteria were: (a) patients under 18 years of age (b) traumas who
were transferred from another medical facility with IV therapy already in place, and (c)
incomplete or missing data.
COLLECTION OF DATA AND CHART REVIEW
Data gathered included age, gender, where the PIVC was started (inside /outside
the ED), PIVC gauge, anatomical location of PIVC, the injury severity score (ISS), and
the presence/absence of phlebitis. Phlebitis severity was measured by assigning a
numerical score on a phlebitis scale of 0 to 5; (Phlebitis Criteria for Judging Newborn
Pediatric Adult Tool, 2007) with a lower total score implying less severe phlebitis. All IV
therapy requires daily assessment for signs and symptoms of phlebitis, and a rating score
of 2 or higher indicates the first sign of phlebitis, (pain and redness). The cannula was
usually removed at this hospital when a score of 2 was assigned (Refer to Appendix 1 for
phlebitis scores).
DATA ANALYSIS
Data were analyzed using SAS. Descriptive statistics were determined for all
variables before calculating a GLM for all variables. The Chi Square (x2) test-to-test was
also run to determine differences in phlebitis rates according to where the PIVC was
started (inside or outside the ED). An alpha level of p <0.05 was used.
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RESULTS
Out of 634 Trauma One and Trauma Evals admitted to the ED, 494 patients
initially met the inclusion criteria. However, not all of these 494 records had complete
data, therefore only 432 (244 men and 188 women) patient’s records were used in
analyses (87.45% complete information). Despite the fact that phlebitis data was recorded
only in the narrative and not on the phlebitis assessment tool, the specific phlebitis score
could still be determined and was used. The mean patient age was 47.12 years (range, 1895 years) and the mean number of days before the first phlebitis indication was 3.14 days
with a range of 1-6 days and a SD of 1.378 days. (Refer to other descriptive statistics in
Table 1)
The overall phlebitis rate for the 432 trauma patients was 5.79 %. The rate of
phlebitis when the PIVC was started in the ED was 2.92%. The rate of phlebitis when the
PIVC was started outside the ED was 6.94%. If the PIVC was started outside the ED by
EMTs the rate was 6.09%. When the PIVC was started outside the ED by paramedics the
rate was 7.78%. There was no statistically significant difference in rates according to
where the PIVC was started, (x2 3.3933; p < 0.18). The regression analysis using the
anatomical placement site, gender, age, ISS score and IV gauge as predictors for phlebitis
in all patients was not significant. Regression analyses using these same variables as
predictors for phlebitis in patients where the PIVC was started inside the ED or outside
the ED were not significant.
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DISCUSSION
This pilot study not only examined phlebitis rates in trauma patients, but also
sought to determine if phlebitis rates in these patients varied according to whether the
PIVC was started inside the Emergency Department by Registered Nurses, or outside the
Emergency Department by EMS Personnel (EMTs/Paramedics). The study also sought to
discover predictors of phlebitis in these trauma patients, a discussion of findings
according to the research questions follows.
What is the phlebitis rate in trauma patients? The overall phlebitis rate in trauma
patients in this study was 5.79%. According to the literature, phlebitis rates in patients
range from 5-70% (Gallant & Schultz, 2006), but phlebitis rates are unknown for patients
experiencing trauma. These results are certainly within this range and in fact, very close
to the lowest range of phlebitis rates reported in the literature. However, further
investigation is warranted since the ranges reported in the literature for phlebitis rates are
for all patients rather than those experiencing trauma.
Is there a difference in phlebitis rates in trauma patients according to whether the
PIVC was started inside or outside the ED? Results indicated the rate of phlebitis for
PIVCs started in the ED was 2.92%, and the overall rate of phlebitis when the PIVC was
started outside the ED was 6.94%. If the PIVC was started by EMT’s outside the ED the
phlebitis rate was 6.09%. If the PIVC was started outside the ED by paramedics the rate
was 7.78%. According to x2 analysis there were no differences in these rates. The finding
is surprising since the literature suggests the phlebitis rates of PIVCs started outside the
hospital (in the field) is 4.65 times higher than PIVC’s started in the emergency
department (Lawrence & Lauro, 1988). Reasons for this difference are unclear and
further investigation is warranted.
What variables predict phlebitis in trauma patients whose PIVC was started in the
emergency department? None of the variables examined in this study (age, gender,
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catheter duration, PIVC anatomical site placement, PIVC gauge, and the ISS), predicted
phlebitis in trauma patients whose PIVC was started inside the ED. The finding was not
anticipated since the literature suggests many of these variables can be causes of
phlebitis. The findings are surprising and further investigation is warranted. Other
variables not examined in this study (type of IV solutions or IV medications) may also
predict the development of phlebitis in trauma patients. However means for the
investigation of (type of IV solutions or IV medications) were not feasible and should
therefore be investigated in future studies.
What variables predict phlebitis in trauma patients whose PIVC was started outside
the hospital? None of the variables examined in the study (age, gender, catheter duration,
PIVC anatomical site placement, PIVC gauge size, and ISS) predicted phlebitis in
patients whose PIVC was started outside the hospital. This finding is also surprising and
in fact unanticipated since the literature suggests the phlebitis rate in patients whose
PIVC was started outside the hospital is 4.65 times higher than the phlebitis rate of
patients whose PIVC was started inside the hospital (Lawrence & Lauro, 1998). Indeed,
further investigation of phlebitis rates in patients whose PIVC is started outside the
hospital is warranted; additional studies are needed to examine phlebitis rates in trauma
patients specifically. This is especially important because the research related to phlebitis
rates in IVs started outside the hospital (Lawrence & Lauro, 1988) is almost 20 years old,
and evaluation for healthcare personnel starting PIVCs outside the hospital probably has
changed in the last 20 years. The specific type of material of which catheters are made of
now has also changed. In fact, the CDC recommends using catheters made of Teflon®
polyvinyl chloride or polyethylene since they are most resistant to microorganism’s
adherence. The use of a skin antiseptic of 2% chlorhexidine (CDC, 2002) is also now
Standard Care whenever starting a PIVC.
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LIMITATIONS
Even though this pilot study provided new and helpful information regarding
phlebitis rates in trauma patients, there are at least six limitations to the study. First,
neither medication therapy nor how often intravenous tubing was monitored or changed
was recorded. In addition, no bacterial catheter tip cultures were performed on those
PIVCs that were removed. Four, the presence of underlying medical conditions in these
trauma patients (blood dyscrasia or autoimmune disease) which may increase the
incidence of phlebitis were not studied. Five, although patients were brought to the ED
with multiple IV’s, only one IV per patient was used for analyzing the presence or
absence of phlebitis. Finally, the study was limited to one geographical location.
IMPLICATIONS AND RECOMMENDATIONS
Although the phlebitis rates in trauma patients examined in this study were very
low, and no difference in the phlebitis rate was noted according to where the IV was
started, continued monitoring of phlebitis rates is critical. In addition, providing
information about the importance of maintaining a sterile or aseptic field when starting a
PIVC in the field is important so the rates reported in the study continue to remain low.
Finally, even though 87.45% of patient records examined were used in the study, it is still
important to reinforce the necessity of accurate and complete documentation. Medical
record entries must also be legible, and timely. Phlebitis scores should be documented as
a requirement per Joint Commission on Accreditation of Healthcare organizations
(JCAHO), as opposed to creating verbose narrative. A complete objective description of
the PIVC placement procedure, the site of insertion, the gauge used and the patient’s
response to treatment can improve charting, and aid future researchers who need
complete information about patient conditions they are studying.
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CONCLUSION
Evaluation of PIVC’s started in the ED versus PIVC started outside the ED did not
show significant differences in the incidence of phlebitis in trauma patients. In addition,
the phlebitis rates of patients in the study were much lower than previously reported in
the literature. Finally, no variables studied (age, gender, length of time the PIVC is in
place, the anatomical insertion site of PIVC, the catheter gauge, whether the PIVC was
placed inside or outside the emergency department, and ISS) were found to predict
phlebitis. Further study is warranted not only in trauma patients but also in all patients
since revised and lower incidences of phlebitis may now be the norm, and no information
about the phlebitis rates in trauma patients especially currently exists in the literature.
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TABLE
Table 1
Frequency of Gender, where IV Started (inside/outside ED), IV Gauge, Size, Anatomical
Placement of PIVC and ISS
Percent

Frequency

56.48
43.52

244
188

Gender
Male
Female
IV Started
Emergency Room
Outside Paramedics
Outside EMT’s I, II
Gauge Size
14g
16g
18g
20g
22g
24g

Total
432

432
31.71
41.67
26.62

137
180
115
432

0.7
5.6
55.6
34.7
3.2
0.2

3
24
240
150
14
1

Anatomical Location
AC (antecubital)
FA (Forearm)
Wrist
Hand
Arm
Other

432
54.2
17.1
7.2
17.1
3.7
0.7

234
74
31
74
16
3

Injury Severity Score (ISS)
Minimal (0-14)
Moderate (15-24)
Severe (25-75)

65.74
18.29
15.97

284
79
69

432
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APPENDIX A
Last update: 02-15-2007- document version: 3
Phlebitis Criteria for Judging Newborn Pediatric Adult Tool (2007)
Severity
Adult Criteria
0
No pain at IV site, no erythema, no swelling, no
induration, no palpable venous cord
1+
Painful IV site, no erythema, no swelling, no induration,
palpable venous cord
2+
Painful IV site with erythema or some degree of
swelling, or both, no induration, no palpable venous cord
3+
Painful IV site w/ erythema and swelling and w/
induration or a palpable venous cord less than three inches
above IV site
4+
Painful IV site, erythema, swelling, induration and
palpable venous cord greater than three inches above IV site
5+
Frank vein thrombosis along w/ all sings of 4+, IV may
have stopped running d/t thrombosis. May have pus at site
©2004 (first published), 2007 (last revision), IHC Health Services, Inc.
This guideline is designed for the general use of most patients, but may need to be
adapted to meet the special needs of a specific as deter by the patient’s health care
provider.

